Concepedia

Author

Yongjie Xie

Tianjin Medical University Cancer Institute and HospitalORCID

Also Known As

Shiqi Zhang, Xie, Yongjie, Y Xie, Y. Xie, Yansu Xie, Yaowu Xie, Yongjie Xie, Yuanguang Xie, Yunming Xie

66

Publications

448

Citations

12

H-Index

19

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and HospitalTianjin Medical UniversityPenn State Milton S. Hershey Medical CenterNankai UniversityNational Clinical Research
YX

About

Yongjie Xie is an author at Tianjin Medical University Cancer Institute and Hospital specializing in immunology, medicine, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

87

2

Immunology

3

3

87

3

Cell Biology

2

2

58

4

Cancer Cell Biology

1

1

21

5

Cell Signaling

1

1

21

Yongjie Xie

×

14

Publications

375

Citations

12

H-Index

YearCitations

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Tianxing Zhou, Yongjie Xie, Xupeng Hou,

Journal of Experimental & Clinical Cancer Research

2023

73

ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4

Tianxing Zhou, Jing Liu, Yongjie Xie,

Gut

2021

48

SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation

Jing Liu, Weiwei Bai, Tianxing Zhou,

Gut

2023

39

Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells

Kaiyuan Wang, Bo Ni, Yongjie Xie,

Cell Research

2025

37

Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy

Yongjie Xie, Tianxing Zhou, Xueyang Li,

Gastroenterology

2024

29

Triple‐negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding

Xupeng Hou, Xueyang Li, Yunwei Han,

Cancer

2024

24

Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress

Chunhua She, Chao Wu, Weihua Guo,

Journal of Experimental & Clinical Cancer Research

2023

23

Identification of Ferroptosis-Related Genes Signature Predicting the Efficiency of Invasion and Metastasis Ability in Colon Adenocarcinoma

Chunlei Shi, Yongjie Xie, Xueyang Li,

Frontiers in Cell and Developmental Biology

2022

21

Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer

Chenying Liu, Xiaolong Qian, Chunyan Yu,

Cancer Letters

2024

21

Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma

Tianxing Zhou, Quan Man, Xueyang Li,

Cancer Biology and Medicine

2023

14

Page 1